References
- Walsh TJ, Chanock SJ. Diagnosis of invasive fungal infections: advances in nonculture systems. Curr Clin Top Infect Dis 1998; 18: 101–153.
- Creger RJ, Weeman KE, Jacobs MR, et al. Lack of utility of the lysis-centrifugation blood culture method for detection of fungemia in immunocompromised cancer patients. J Gun Mi-crobiol 1998; 36: 290–293.
- Geha DJ, Roberts GD. Laboratory detection of fungemia. Clin Lab Med 1994; 14: 83–97.
- Reimer LG, Wilson ML, Weinstein MP. Update on detection of bacteremia and fungemia. Gun Microbiol Rev 1997; 10: 444–465.
- Warren NG, Hazen KC. Candida, Cryptococcus, and Other Yeasts of Medical Importance. In: Murray PR, ed. Manual Clinical Microbiology. Washington, DC: ASM Press, 1999: 1184–1199.
- San Millan R, Ribacoba L, Ponton J, Quindos G. Evaluation of a commercial medium for identification of Candida species. Eur J Clin Microbiol Infect Dis 1996; 15: 153–158.
- Shin JH, Nolte FS, Morrison CJ. Rapid identification of Can-dida species in blood cultures by a clinically useful PCR method. J Clin Microbiol 1997; 35: 1454–1459.
- NCCLS. Reference Method for Broth Dilution Antifungal Sus-ceptibility Testing of Yeasts; Approved Standard. M27-A, i-32. Villanova, PA: NCCLS, 1997.
- Lozano-Chiu M, Paetznick VL, Ghannoum MA, Rex JH. Detection of resistance to amphotericin B among Cryptococcus neoformans clinical isolates: performances of three different media assessed by using E-test and National Committee for Clinical Laboratory Standards M27-A methodologies. J Gun Microbiol 1998; 36: 2817–2822.
- Gould IM, Milne K, Wood W, Kunova A. Comparison of the E test with broth microdilution for antifungal susceptibility testing of yeasts. J Chemother 1998; 10: 3–6.
- Chryssanthou E, Gronfors C, Khanna N. Comparison of broth macrodilution, broth microdilution and E-test susceptibility tests of Cryptococcus neoformans for iluconazole. Mycoses 1997; 40: 423–427.
- Simor AE, Goswell G, Louie L, Lee M, Louie M. Antifungal susceptibility testing of yeast isolates from blood cultures by microbroth dilution and the E test. Eur J Gun Microbiol Infect Dis 1997; 16: 693–697.
- Berenguer J, Buck M, Witebsky F, Stock F, Pizzo PA, Walsh TJ. Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. Disseminated versus sin-gle-organ infection. Diagn Microbiol Infect Dis 1993; 17: 103–109.
- Reiss E, Lehmann PF. Galactomannan antigenemia in invasive aspergillosis. Infect Immun 1979; 25: 357–365.
- Maertens J, Verhaegen J, Demuynck H, et al. Autopsy-con-trolled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive aspergillo-sis. J Gun Microbiol 1999; 37: 3223–3228.
- Obayashi T, Yoshida M, Mori T, et al. Plasma (1,3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 1995; 345: 17–20.
- Mori T, Ikemoto H, Matsumura M, et al. Evaluation of plasma (1,3)-beta-D-glucan measurement by the kinetic turbidimetric Limulus test, for the clinical diagnosis of mycotic infections. Eur J Clin Chem Clin Bioch 1997; 35: 553–560.
- Yoshida M, Obayashi T, Iwama A, et al. Detection of plasma (1,3)-beta-D-glucan in patients with Fusarium, Trichosporon, Saccharomyces and Acremonium fungaemias. J Med Vet Mycol 1997; 35: 371–374.